Application Deadline: 17.02.2019
Registration Fee (100.00€)
Exciting and significant new developments and advantages in the diagnosis, treatment and patient prognosis of cystic fibrosis (CF) have been achieved in recent years. However, CF remains a highly prevalent, multi-organ and severe life-limiting genetic disorder with important gastrointestinal, hepatologic and nutritional implication in children. And with the improved treatment of the pulmonary complications of cystic fibrosis (CF), gastrointestinal nutritional problems have become more important in the morbidity of CF patients.
The CF phenotype results from mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) protein. As a result, the CF patients have, besides progressive lung disease several gastrointestinal, hepatologic and nutritional complications leading to a negative impact on disease evolution and life expectancy.
In recent years there has been a huge and significant progress in the knowledge of the disease regarding genetics, pathogenesis, medical and nutritional management, new treatments, personalized medicine and patient self-management.
The aim of this Monothematic Conference on CF is, by using classical as modern interactive educational tools, to give a comprehensive overview on the current status and new development regarding the disease, in particular its gastrointestinal, hepatologic and nutritional implication to provide a broad practical and scientific insight into recent findings in the field.
Local organisers: Carmen Ribes Koninckx (Spain), Frank Bodewes (the Netherlands), Michael Wilschanski (Israel)
Kris De Boeck
Karin de Winter